Dr. Joseph Martel, MD
Claim this profileUPMC Eye Center
Studies Fungal Retinitis
Studies Retinitis Pigmentosa
8 reported clinical trials
16 drugs studied
Area of expertise
1Fungal Retinitis
RHO positive
PDE6A positive
PDE6B positive
2Retinitis Pigmentosa
RHO positive
PDE6A positive
PDE6B positive
Affiliated Hospitals
Clinical Trials Joseph Martel, MD is currently running
Gene Therapy with Light-Stimulating Glasses
for Retinitis Pigmentosa
This trial is testing a new gene therapy injected into the eye and special light-stimulating glasses for patients with a specific type of vision loss called non-syndromic Retinitis Pigmentosa. The gene therapy aims to fix genetic problems in the eye, while the glasses help activate the treated cells. Gene therapy has shown promise in treating retinal diseases.
Recruiting1 award Phase 1 & 2
AGTC-501
for Retinitis Pigmentosa
This study will evaluate and compare the safety, efficacy, and tolerability of 2 doses of a recombinant adeno-associated virus vector (AGTC-501/laruparetigene zovaparvovec )) to an untreated control group in male participants with X-linked retinitis pigmentosa caused by RPGR mutations.
Recruiting1 award Phase 2 & 3
More about Joseph Martel, MD
Clinical Trial Related6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Joseph Martel, MD has experience with
- Placebo
- VVN461 Ophthalmic Solution
- PRIMA
- GS030-DP
- GS030-MD
- Mycophenolic Acid
Breakdown of trials Joseph Martel, MD has run
Fungal Retinitis
Retinitis Pigmentosa
Dry Eye Syndrome
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
- Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease
Eye Disorder
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
- Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph Martel, MD specialize in?
Joseph Martel, MD focuses on Fungal Retinitis and Retinitis Pigmentosa. In particular, much of their work with Fungal Retinitis has involved RHO positive patients, or patients who are PDE6A positive.
Is Joseph Martel, MD currently recruiting for clinical trials?
Yes, Joseph Martel, MD is currently recruiting for 3 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Joseph Martel, MD has studied deeply?
Yes, Joseph Martel, MD has studied treatments such as Placebo, VVN461 Ophthalmic Solution, PRIMA.
What is the best way to schedule an appointment with Joseph Martel, MD?
Apply for one of the trials that Joseph Martel, MD is conducting.
What is the office address of Joseph Martel, MD?
The office of Joseph Martel, MD is located at: UPMC Eye Center, Pittsburgh, Pennsylvania 15213 United States. This is the address for their practice at the UPMC Eye Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.